Healthcare solutions and retail pharmacy activities will be separated in the first half of 2028
AI-generated summary
CVS Health has decided to restructure its operations following a comprehensive strategic evaluation process conducted by its board of directors. The company aims to create two independent public companies in healthcare solutions and retail pharmaceuticals.
US-based healthcare company CVS Health announced that it plans to create two independent companies by separating its activities in retail pharmacy and healthcare solutions.
In the statement made by CVS Health, it was stated that the board of directors decided to restructure the company's operations after a comprehensive strategic evaluation process.
In this context, it was reported that it is aimed to establish two independent publicly held companies that will operate in the fields of health solutions and retail pharmacy.
It was noted that the first company to operate in the field of health solutions will include Aetna, CVS Caremark, CVS Specialty, Oak Street Health and Signify Health. It was reported that the company in question will continue to use the name CVS Health during the transition period.
It was stated that the second company that will undertake retail pharmacy activities will operate under the name CVS Pharmacy. It was stated that this company will include approximately 9 thousand CVS pharmacies, pharmacy services offered by mail, MinuteClinic and Health100 technology services.
The separation is expected to be completed in the first half of 2028.
In the statement, it was stated that both companies will continue their activities with more focused strategies and independent capital structures. It was noted that the companies are expected to have strong free cash flow and investment grade credit ratings.
It was reported that the separation process is expected to be completed in the first half of 2028, after obtaining the necessary approvals and meeting the relevant conditions.
It was stated that upon completion of the process, existing CVS Health shareholders will own shares of both companies.
It was emphasized that CVS Health will continue its current operations and continue to provide uninterrupted service to its customers until the separation process is completed.
AI outlook — possibilities, not facts
The separation process will be completed in the first half of 2028.
Likely · Within months

Istanbul Provincial Health Directorate will hold an open tender for the procurement of top-of-page printout services for 2027. The tender will be opened on 27.11.2026, the work period is determined as 01.01.2027-31.12.2027. 15 million black and white printouts and 160 thousand color printouts are requested.

Tuzla Municipality Business and Affiliates Directorate is holding an open tender on 27 November 2026 for the purchase of a total of 26,990 kg of red meat to be used in social facilities. Only local bidders can participate and there will be no electronic auction.

Minister of Commerce Ömer Bolat answered the questions of the MPs after the 2027 budget discussions at the Grand National Assembly of Turkey Planning and Budget Commission. He made evaluations on market stability, grant support to women's cooperatives, lemon prices, customs gates and exports.
It was reported that 62.2 billion liras were paid to 390 thousand 219 investors within the scope of extraordinary liquidation, and 55.4 billion liras were paid to 55 thousand 821 investors within the scope of ordinary liquidation. The entire principal amount was covered for 133 thousand 839 investors.
Interim payments continue to the owners of the investment funds that were decided to be liquidated in line with the Law No. 7596 adopted by the Turkish Grand National Assembly on October 22 and the CMB's decision No. 76/1903 dated October 27. Within the scope of extraordinary liquidation, 62.2 billion liras were paid to 390 thousand 219 investors; The principal of 133 thousand 839 of these investors was fully covered.
Within the scope of extraordinary liquidation in capital market transactions, 62.2 billion TL was paid to 390 thousand 219 investors; 133 thousand 839 investors received their entire principal money. Within the scope of ordinary liquidation, a total of 55.4 billion TL was paid to 55 thousand 821 investors.